• Explore /
  • Poster
  • / Adaptively randomized trial of neoadjuvant chemotherapy with or without the Akt inhibitor MK-2206: Graduation results from the I-SPY 2 Trial.

Adaptively randomized trial of neoadjuvant chemotherapy with or without the Akt inhibitor MK-2206: Graduation results from the I-SPY 2 Trial.

Abstract Poster

Authors

null

Debu Tripathy

The University of Texas MD Anderson Cancer Center, Houston, TX

Debu Tripathy , Amy Jo Chien , Nola Hylton , Meredith Becker Buxton , Cheryl Ann Ewing , Anne M. Wallace , Andres Forero , Henry G. Kaplan , Rita Nanda , Kathy S. Albain , Stacy L. Moulder , Barbara B. Haley , Angela DeMichele , William Fraser Symmans , Laura van 't Veer , Melissa Paoloni , Laura Esserman , Donald A. Berry , Douglas Yee

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Breast Cancer—HER2/ER

Track

Breast Cancer

Sub Track

HER2+

Clinical Trial Registration Number

NCT01042379

Citation

J Clin Oncol 33, 2015 (suppl; abstr 524)

DOI

10.1200/jco.2015.33.15_suppl.524

Abstract #

524

Poster Bd #

12

Abstract Disclosures

Similar Posters

First Author: Anuradha Belur

First Author: Alexandra Thomas

First Author: Katsuhiko Nakatsukasa

First Author: Louis Fehrenbacher